Forbes @Forbes
The FDA’s decision to grant accelerated approval for the anti-Alzheimer’s drug lecanemab, which will be sold as Leqembi, has significant potential for research into treatment of the disease. https://t.co/9EzXCnicOQ — PolitiTweet.org
Created
Mon Jan 09 16:30:18 +0000 2023
Likes
32
Retweets
12
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Forbes @Forbes
The FDA’s decision to grant accelerated approval for the anti-Alzheimer’s drug lecanemab, which will be sold as Leqembi, has significant potential for research into treatment of the disease. https://t.co/9EzXCnicOQ — PolitiTweet.org